MedPath

Identification of Susceptibility to Abacavir Hypersensitivity Reaction (HSR) in HIV-1 Infected Patients in Sydney, Australia and Development of Mechanisms for Risk Reductio

Not Applicable
Conditions
Human Immunodeficiency Virus Type-1 (HIV-1)
Infection - Acquired immune deficiency syndrome (AIDS / HIV)
Registration Number
ACTRN12607000030471
Lead Sponsor
Holdsworth House Medical Practice
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

1. Documented HIV-1 infection. 2. Abacavir treatment naive or 3. Previous abacavir HSR. 4. Able to understand and willing to sign informed consent. 5. Able to return for discussion of B*5701 test results.

Exclusion Criteria

1. Previous abacavir exposure with no diagnosis of abacavir HSR 2. Patients unable to submit a blood sample 3. Unable to understand English where translator not available.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath